Latha Vairavan serves as Executive at Arcutis Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Latha Vairavan has executed 3 insider transactions totaling $37.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 2, 2026 involved selling 1,320 shares valued at $33.7K.
Latha Vairavan currently holds 63,607 shares of Arcutis Biotherapeutics, Inc. (ARQT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Latha Vairavan has been a net seller of ARQT stock. They have purchased $0 and sold $37.1K worth of shares.
Latha Vairavan's most recent insider trade was on Feb 2, 2026, when they sold 1,320 shares at $25.50 per share.
Get notified when new Form 4 filings are submitted
| $24.72 |
| Discretionary |
| Aug 4, 2025 | ARQT | $1.3K | Sale | 89 | $14.33 | Discretionary |